# Daniel Oliver

> Daniel Oliver is a seed investor at Capital Cell (Barcelona) backing Health Care and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Capital Cell](https://shizune.co/investors/profile/capital-cell)
- Location: Barcelona, Spain
- Total investments: 1
- Last investment: Mar 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/daniel-oliver-1949a025/

Daniel Oliver is a seed investor at Capital Cell in Barcelona focused on Health Care and Biotechnology. Director at Capital Cell.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MSInsight | MSInsight bioinformatics start-up that develops diagnostic and treatment response prediction solutions for Microsatellite Instability (MSI) cancers. Its service offering focuses on diagnostic and prognostic biomarkers of treatment response for MSI tumors. | $1.7M | Seed | Mar 10, 2025 |  |

1 of 1 investments shown.

## Co-investors
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 1 deal together
- [Calyseed](https://shizune.co/investors/profile/calyseed) — VC Fund, 1 deal together
- [Plateau de Saclay Business Angels](https://shizune.co/investors/profile/plateau-de-saclay-business-angels) — VC Fund, 1 deal together
- [YES invest](https://shizune.co/investors/profile/yes-invest) — VC Fund, 1 deal together

## About Capital Cell

VC Fund · Barcelona, Spain

Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.

4 contacts available at Capital Cell.

| Name | Title | Profile |
| --- | --- | --- |
| Daniel Oliver | Director | https://shizune.co/investors/profile/daniel-oliver-2 |
| Joan Marcos | General Manager | https://shizune.co/investors/profile/joan-marcos |
| Patrick O'Brien | Investment Manager | https://shizune.co/investors/profile/patrick-o-brien-69e6 |
| Patrick O'Brien | Investment Manager | https://shizune.co/investors/profile/patrick-o-brien-6 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Daniel Oliver invest in?

Daniel Oliver invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Daniel Oliver last invest?

The most recent investment recorded for Daniel Oliver closed in Mar 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
